ALBANI, MARCO
ALBANI, MARCO
Dipartimento di Scienze Farmaceutiche
DESIGN AND DEVELOPMENT OF RNA-BASED DRUGS USING MOLECULAR DYNAMICS SIMULATIONS AND ARTIFICIAL INTELLIGENCE METHODS
2026 M. Albani
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment
2025 M. Voi, A. Sangalli, E.G. Milano, C. De Martinis, E. Orlandi, S. Tamburin, E. Mantovani, A. Federico, M. Lanzafame, E. Lattuada, G.A. Argañaraz, B.C.M. Da Silva, A.J. Da Silva Duarte, J. Casseb, E.R. Argañaraz, M. Malena, M. Albani, A. Ruggiero, M.G. Romanelli, M.T. Valenti, G. Grazioso, D. Zipeto
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
2025 E.M.A. Fassi, N. Mekni, M. Albani, S. Maehrlein, A.C. Weldert, T. Schirmeister, T. Langer, G. Grazioso
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer
2025 E.M.A. Fassi, R.M. Moretti, M. Montagnani Marelli, M. Garofalo, A. Gori, C. Pesce, M. Albani, E.G. Milano, J. Sgrignani, A. Cavalli, G. Grazioso
PCSK9 inhibitors: a patent review 2018-2023
2024 E.M.A. Fassi, A. Citarella, M. Albani, E.G. Milano, L. Legnani, C. Lammi, A. Silvani, G. Grazioso
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines
2024 M. Albani, E.M.A. Fassi, R.M. Moretti, M. Garofalo, M. Montagnani Marelli, G. Roda, J. Sgrignani, A. Cavalli, G. Grazioso